Show simple item record

dc.contributor.authorMartínez Abad, Beatriz
dc.contributor.authorGarrote Adrados, José Antonio 
dc.contributor.authorBernardo, David
dc.contributor.authorMontalvillo Álvarez, Enrique
dc.contributor.authorEscudero Hernández, Celia
dc.contributor.authorVázquez, Enrique
dc.contributor.authorRueda, Enrique
dc.contributor.authorArranz Sanz, Eduardo 
dc.date.accessioned2017-03-07T16:15:34Z
dc.date.available2017-03-07T16:15:34Z
dc.date.issued2013
dc.identifier.citationPlos ONE, November 2013, vol.8, n.11. p.11-12es
dc.identifier.urihttp://uvadoc.uva.es/handle/10324/22468
dc.descriptionProducción Científicaes
dc.description.abstractIn this study we have identified, for the first time to our knowledge plasma CD-specific IgA Abs that recognize as specific antigen a novel deamidated gliadin peptide (FPLQPEQP), derived from an 8-mer peptide generated during duodenal degradation of gliadin by CD-specific duodenal proteases. The native peptide (FPLQPQQP) remained restricted to prolamin and glutenin proteins from toxic cereals to CD patients and was particularly expressed in ω-prolamins. The 8-mer peptide overlapped with a previously identified gluten T cell epitope and its ability to develop a humoral immune response in vivo in CD patients was confirmed by the detection of IgA anti-DGP 8-mer Abs in plasma samples from those patients. The DGP 8-mer could be used as a novel specific CD antigen for the diagnosis of CD and monitoring of the compliance of GFD. We have designed an ELISA test which detects IgA anti-DGP 8-mer Abs in plasma samples from CD- patients with a high specificity (94% in children and 98.8% in adults) and sensitivity (93.5% in children and 81.3% in adults). Future studies with larger number of samples and additional relevant data (i.e. use of novel tools for GFD compliance) will assess the full potential of the novel diagnostic tool for celiac diagnosis and management.es
dc.format.mimetypeapplication/pdfes
dc.language.isoenges
dc.publisherPublic Library of Sciencees
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectEnfermedad celíaca - Diagnósticoes
dc.titleDifferential immunomodulatory effects of Lactobacillus rhamnosus DR20, Lactobacillus fermentum CECT 5716 and Bifidobacterium animalis subsp. lactis on monocyte-derived dentritic cellses
dc.typeinfo:eu-repo/semantics/articlees
dc.identifier.publicationfirstpage1es
dc.identifier.publicationissue11es
dc.identifier.publicationlastpage12es
dc.identifier.publicationtitlePLOSes
dc.identifier.publicationvolume8es
dc.peerreviewedSIes
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record